These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 802852)

  • 41. Pretransplant immunologic reactivity to donor lymphocytes--lack of correlation with posttransplant events.
    Keown PA; Stiller CR; Bloch M; Sinclair NR; Lockwood BA; Howson WH
    Transplant Proc; 1981 Sep; 13(3):1563-4. PubMed ID: 7029815
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cellular immunity in actively conditioned recipients of renal allotransplants (author's transl)].
    Haefen UV; Garovoy MR; Wren SF; Martins AC; Wilson RE
    Dtsch Med Wochenschr; 1975 Feb; 100(8):370-2. PubMed ID: 234839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [HLA and rejection of renal transplants from cadavers].
    Zanuso C; Pontiero P; Ancona G; Muolo A; Confortini P
    Minerva Chir; 1980 May; 35(10):793-5. PubMed ID: 7005737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The HLA system. An introduction].
    Rutayungwa ET; Zantvoort FA; Lison AE
    Urologe A; 1994 Sep; 33(5):360-4. PubMed ID: 7974922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients.
    Falk RE; Guttmann RD; Falk JA; Beaudoin JG; Deveber G; Morehouse DD; Wilson DR
    Clin Exp Immunol; 1973 May; 14(1):47-56. PubMed ID: 4577287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 48. [Histocompatibility tests in a transplantation program].
    de-Leo-Cervantes C
    Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of HLA-D matching on the outcome of intrafamilial kidney transplantation with special emphasis on the predictive value of the relative response in MLC.
    Berg B; Groth CG; Lundgren G; Magnusson G; Möller E; Ringdén O
    Scand J Urol Nephrol Suppl; 1981; 64():46-51. PubMed ID: 6216584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunological response of the recipient of a renal allograft].
    Hamburger J; Bach JF
    Ann Med Interne (Paris); 1973 Feb; 124(2):91-4. PubMed ID: 4146739
    [No Abstract]   [Full Text] [Related]  

  • 51. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [HLA-amino acid residue matching in organ transplantation].
    Tan J; Tang X; Zhou Y
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):31-3. PubMed ID: 11831982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antigen-specific rosette inhibition test with autologous serum--a possibility for the detection of blocking factors in chronic rejection of allogeneic orthotopic kidney transplants].
    Werner M; Keitel R; Sauer H; Klötzer B; Kothe W; Ambrosius H
    Z Exp Chir Transplant Kunstliche Organe; 1984; 17(3):188-99. PubMed ID: 6380128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An immunological study of renal allograft rejection using the direct macrophage inhibition test.
    Turnipseed WD; Cerilli J
    Transplantation; 1975 Nov; 20(5):414-9. PubMed ID: 1108315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship of mixed lymphocyte culture (MLC) response and kidney graft survival in living related donor transplants.
    Lazda VA; Jonasson O; Mozes MF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):949-52. PubMed ID: 6455829
    [No Abstract]   [Full Text] [Related]  

  • 58. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
    Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
    Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current immunologic aspects of kidney transplantation].
    Lenhard V; Dreikorn K; Opelz G
    Urologe A; 1982 Sep; 21(5):280-9. PubMed ID: 6758280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The HL-A complex in kidney transplantation.
    Dausset J
    Clin Nephrol; 1974; 2(1):1-3. PubMed ID: 4274665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.